Milestone Pharma gets FDA approval for first PSVT nasal spray
Milestone (Nasdaq: MIST) announced FDA approval of CARDAMYST (etripamil) nasal spray for conversion…
Genetic variation in the glucagon-like peptide-1 receptor protein encoding region is associated with higher heart rate variability, but not with neurodegeneration of the brain, retina, and peripheral nerves: The Maastricht study | Cardiovascular Diabetology
Badrov MB, Mak S, Floras JS. Cardiovascular autonomic disturbances in heart failure with preserved ejection fraction. Can J…
This silent heart attack symptom is very common but sometimes turns deadly: Max Hospital cardiologist warns not to ignore
Chest discomfort, bloating, or frequent burping are often dismissed as minor digestive issues, but experts warn they can…
Samsung’s smartwatch gains regulatory approval for LVSD detection, while Brainwave EEG stays in prototype phase
Samsung says that their new tech has been developed in partnership with Medical AI. Pictured – Samsung’s logo…
Study Finds Cocoa Extract Supplement Reduces Key Marker of Aging
A large-scale clinical study suggests that cocoa extract supplements rich in flavanols may help reduce age-related inflammation. Researchers…
One in four Indians faces silent genetic threat to heart health, shows study
In the Asia Pacific and Middle East region, two in three individuals (66%) skip routine heart tests, while…
Neuroimaging in traumatic brain injury: a bibliometric analysis | International Journal of Emergency Medicine
Traumatic Brain Injury (TBI) is a significant cause of death and disability [1, 2]. It is caused by…
Covid vaccinations remain vital to protect global heart health
Regular Covid vaccinations should continue worldwide to reduce cardiac risks associated with the virus – according to new…
Revascularization strategy fails to show noninferiority in STEMI patients
Noninferiority was not demonstrated between immediate and staged complete revascularisation in patients with ST-segment elevation myocardial infarction (STEMI)…
Ivabradine fails to prevent myocardial injury after noncardiac surgery in large clinical trial
Ivabradine did not reduce the occurrence of myocardial injury after noncardiac surgery (MINS), according to late-breaking research presented…
First ESC statement on mental health and heart disease promotes integrated care
A new ESC Clinical Consensus Statement is calling for greater awareness of the multidirectional relationship between mental health…
REBOOT trial finds no benefit of beta blockers after uncomplicated heart attacks
Beta blockers-drugs commonly prescribed for a range of cardiac conditions, including heart attacks-provide no clinical benefit for patients…